Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome

Nat Commun. 2023 Mar 1;14(1):1167. doi: 10.1038/s41467-023-36818-0.

Abstract

Angelman syndrome (AS) is a neurogenetic disorder characterized by intellectual disability and atypical behaviors. AS results from loss of expression of the E3 ubiquitin-protein ligase UBE3A from the maternal allele in neurons. Individuals with AS display impaired coordination, poor balance, and gait ataxia. PIEZO2 is a mechanosensitive ion channel essential for coordination and balance. Here, we report that PIEZO2 activity is reduced in Ube3a deficient male and female mouse sensory neurons, a human Merkel cell carcinoma cell line and female human iPSC-derived sensory neurons with UBE3A knock-down, and de-identified stem cell-derived neurons from individuals with AS. We find that loss of UBE3A decreases actin filaments and reduces PIEZO2 expression and function. A linoleic acid (LA)-enriched diet increases PIEZO2 activity, mechano-excitability, and improves gait in male AS mice. Finally, LA supplementation increases PIEZO2 function in stem cell-derived neurons from individuals with AS. We propose a mechanism whereby loss of UBE3A expression reduces PIEZO2 function and identified a fatty acid that enhances channel activity and ameliorates AS-associated mechano-sensory deficits.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Angelman Syndrome* / drug therapy
  • Angelman Syndrome* / genetics
  • Animals
  • Disease Models, Animal
  • Female
  • Humans
  • Intellectual Disability
  • Ion Channels* / genetics
  • Linoleic Acid* / pharmacology
  • Male
  • Mice

Substances

  • Ion Channels
  • Linoleic Acid
  • PIEZO2 protein, human
  • Piezo2 protein, mouse
  • Ube3a protein, mouse